These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11908767)

  • 1. The pharmacogenomics of HIV therapy.
    Pirmohamed M; Back DJ
    Pharmacogenomics J; 2001; 1(4):243-53. PubMed ID: 11908767
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetic considerations in the treatment of HIV.
    Mattevi VS; Tagliari CF
    Pharmacogenomics; 2017 Jan; 18(1):85-98. PubMed ID: 27976978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific considerations for pharmacoenhancers in antiretroviral therapy.
    Arya V; Robertson SM; Struble KA; Murray JS
    J Clin Pharmacol; 2012 Aug; 52(8):1128-33. PubMed ID: 21712496
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical implications of antiretroviral pharmacogenomics.
    Fox J; Boffito M; Winston A
    Pharmacogenomics; 2006 Jun; 7(4):587-96. PubMed ID: 16753006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?
    Nolan D; Gaudieri S; Mallal S
    J HIV Ther; 2003 May; 8(2):36-41. PubMed ID: 12838163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmacogenetics on HIV therapy.
    Mahungu TW; Johnson MA; Owen A; Back DJ
    Int J STD AIDS; 2009 Mar; 20(3):145-51. PubMed ID: 19255258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-HCV Co-infection therapeutic outcomes have not improved over time.
    Cooper C; Costiniuk C; Giguère P
    HIV Clin Trials; 2009; 10(3):203-6. PubMed ID: 19632960
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvements in protease inhibitor-based HAART.
    Boyle BA
    AIDS Read; 2005 Dec; 15(12):659-60, 662. PubMed ID: 16355596
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicentre cohort experience with double-boosted protease inhibitors.
    Stebbing J; Scourfield A; Koh G; Taylor C; Taylor S; Wilkins E; Gazzard B; Nelson M; Jones R
    J Antimicrob Chemother; 2009 Aug; 64(2):434-5. PubMed ID: 19474068
    [No Abstract]   [Full Text] [Related]  

  • 10. HAART in HIV/AIDS Treatments: Future Trends.
    Lu DY; Wu HY; Yarla NS; Xu B; Ding J; Lu TR
    Infect Disord Drug Targets; 2018; 18(1):15-22. PubMed ID: 28474549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saquinavir, the pioneer antiretroviral protease inhibitor.
    la Porte CJ
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    ;
    HIV Med; 2000 Mar; 1(2):76-101. PubMed ID: 11737331
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():78-9. PubMed ID: 11373790
    [No Abstract]   [Full Text] [Related]  

  • 14. Does atazanavir cause lipodystrophy?
    Gazzard BG; Moyle G
    J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PharmGKB summary: atazanavir pathway, pharmacokinetics/pharmacodynamics.
    Alvarellos M; Guillemette C; Altman RB; Klein TE
    Pharmacogenet Genomics; 2018 May; 28(5):127-137. PubMed ID: 29517518
    [No Abstract]   [Full Text] [Related]  

  • 16. HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?
    Philibert P; Chiche L; Caillères S; Allemand J; Rebaudet S; Delord M; Stavris C; Retornaz F; Khiri H; Halfon P
    AIDS; 2017 Sep; 31(15):2167-2169. PubMed ID: 28692546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to "Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides", by Barreiro et al.
    Nicastri E; Sarmati L; Andreoni M
    AIDS; 2003 Feb; 17(3):447-8. PubMed ID: 12556702
    [No Abstract]   [Full Text] [Related]  

  • 18. Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient.
    Deeks SG; Martin JN
    AIDS; 2001 Jan; 15(1):117-9. PubMed ID: 11192853
    [No Abstract]   [Full Text] [Related]  

  • 19. Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options.
    Naggie S; Hicks C
    J Antimicrob Chemother; 2010 Jun; 65(6):1094-9. PubMed ID: 20418273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus protease inhibitors.
    Kline MW
    Pediatr Infect Dis J; 2003 Dec; 22(12):1085-7. PubMed ID: 14688570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.